medigraphic.com

2023, Number 1

<< Back Next >>

Enf Infec Microbiol 2023; 43 (1)

Leukocytoclastic vasculitis as a manifestation of infective endocarditis. Case report

Mendoza CD, Zepeda TJM, García GGJ, Navarro SLM

Language: Spanish
References: 47
Page: 6-11
PDF size: 368.59 Kb.


ABSTRACT

Leukocytoclastic vasculitis is recognized as inflammation and necrosis of small vessels, it is mediated by immune complexes and its clinical distinction is palpable purpura. Infections are responsible for 1.5% of the cases of this vasculitis, its incidence is even lower in cases of heart valves infection.
Clinical case. A 37-year-old man with chronic kidney disease on hemodialysis, with clinical, microbiological and echocardiographic criteria compatible with infective endocarditis due to
Staphylococcus aureus
. Patient had a leukocytoclastic vasculitis as initial presentation.
Conclusions. In addition to the symptoms, diagnosis must be confirmed with histopathology and performed as soon as possible to rule out systemic, neoplastic, or infectious diseases and thus establish targeted therapy and modify the prognosis.


REFERENCES

  1. Fraticelli, P., Benfaremo, D. y Gabrielli, A., “Diagnosisand management of leukocytoclastic vasculitis”, InternEmerg Med, 2021, 16 (4): 831-841.

  2. Meza-Ayala, C.M., Dehesa-López, E., Ruelas-Perea, A.G.et al., “Vasculitis leucocitoclástica: un reto diagnósticopara el médico internista”, Med Int Mex, 2015, 31 (1):113-118.

  3. Medina-Castillo, D., Cortés-Lozano, N., Vega-González,M.T. y De la Cruz-López, J., “Vasculitis cutánea asociadaa sepsis”, Rev Cent Dermatol Pascua, 2005, 14 (1): 22-25.

  4. Bouiller, K., Audia, S., Devilliers, H., Collet, E., Aubriot,M.H., Leguy-Seguin, V., Berthier, S., Bonniaud, P., Chavanet,P., Besancenot, J.F., Vabres, P., Martin, L., Samson,M. y Bonnotte, B., “Etiologies and prognostic factorsof leukocytoclastic vasculitis with skin involvement: aretrospective study in 112 patients”, Medicine (Baltimore),2016, 95 (28): e4238.

  5. Kim, D.H., Choi, S.R., Lee, K.R. y Yoon, M.S., “Syphilisshowing leukocytoclastic vasculitis”, J Cutan Pathol,2010, 37 (5): 607-608.

  6. Pérez López, I., Aguayo Carreras, P., Navarro-Triviño,F.J., Aneiros Fernández, J. y Ruiz Villaverde, R., “Annularleukocytoclastic vasculitis and infection by Mycoplasmapneumoniae”, Med Clin (Barcelona), 2017, 149 (4): e21.

  7. Herranz, P., Capilla, C., Lázaro, T.E. y Casado, M., “Vasculitisleucocitoclástica asociada a infección por Helicobacterpylori”, Rev Clin Esp, 1998, 198 (11): 779.

  8. Dizbay, M., Hizel, K., Kilic, S., Mutluay, R., Ozkan, Y. yKarakan, T., “Brucella peritonitis and leucocytoclasticvasculitis due to Brucella melitensis”, Braz J Infect Dis,2007, 11 (4): 443-444.

  9. Karaali, Z., Baysal, B., Poturoglu, S. y Kendir, M., “Cutaneousmanifestations in brucellosis”, Indian J Dermatol,2011, 56 (3): 339-340.

  10. Vargas-Ocampo, F., “Diffuse leprosy of Lucio and Latapí:a histologic study”, Lepr Rev, 2007, 78 (3): 248-260.

  11. Meziane, M., Amraoui, N., Taoufik, H. y Mernissi, F.Z.,“Cutaneous leukocytoclastic vasculitis revealing multifocaltuberculosis”, Int J Mycobacteriol, 2013, 2 (4):230-232.

  12. Viala, B., Leblay, P., Casanova, M.L., Jorgensen, C. yPers, Y.M., “Recent hiv infection complicated with leukocytoclasticvasculitis and oligoarthritis”, Med Mal Infect,2014, 44 (6): 284-285.

  13. Curtis, J.L. y Egbert, B.M., “Cutaneous cytomegalovirusvasculitis: an unusual clinical presentation of a commonopportunistic pathogen”, Hum Pathol, 1982, 13 (12):1138-1141.

  14. Lee, H.J., Shin, D.H., Choi, J.S. y Kim, K.H., “Leukocytoclasticvasculitis associated with influenza a virus infection”,J Korean Med Sci, 2012, 27 (12): 1601-1603.

  15. Camprodon Gómez, M., González-Cruz, C., Ferrer, B. yBarberá, M.J., “Leucocytoclastic vasculitis in a patientwith covid-19 with positive sars-cov-2 pcr in skin biopsy”,bmj Case Rep, 2020, 13 (10): e238039.

  16. Engel, F., Maradeix, S., Braun-Parvez, L., Lipsker, D. y Cribier,B., “Vasculite leucocytoclasique compliquée d’uneatteinte rénale grave au décours d’une primo-infection àparvovirus b19”, Ann Dermatol Venereol, 2007, 134 (2):160-163.

  17. Cao, S. y Sun, D., “Leucocytoclastic vasculitis followinginfluenza vaccination”, bmj Case Rep, 2017, 2017,bcr2016217755.

  18. Bostan, E., Gulseren, D. y Gokoz, O., “New-onset leukocytoclasticvasculitis after covid-19 vaccine”, Int J Dermatol,2021, 60 (10): 1305-1306.

  19. Pulido, A., Avilés, J.A. y Suárez, R., “Vasculitis cutáneas”,Actas Dermosifiliogr, 2012, 103 (3): 179-191.

  20. Sator, P.G., Feldmann, R., Wanke, T., Gschnait, F. y Breier,F., “Leukozytoklastische eosinophile vaskulitis bei eosinophilemlungeninfiltrat ‘Löffler’”, Hautarzt, 2007, 58 (5):440, 442-444.

  21. Haehn, D.A., Patel, A., Youngberg, G. y González-Estrada,A., “Ceftriaxone-induced leucocytoclastic vasculitis”,bmj Case Rep, 2019, 12 (4): e229411.

  22. Mericliler, M., Shnawa, A., Al-Qaysi, D., Fleisher, J. y Moraco,A., “Oxacillin-induced leukocytoclastic vasculitis”,idcases, 2019, 17: e00539.

  23. Koutkia, P., Mylonakis, E., Rounds, S. y Erickson, A.,“Cutaneous leucocytoclastic vasculitis associated withoxacillin”, Diagn Microbiol Infect Dis, 2001, 39 (3):191-194.

  24. Liedke, C., Nomani, H., Lozeau, D. y Yao, Q., “Apixaban-induced leukocytoclastic vasculitis”, J Clin Rheumatol,2021, 27 (5): e172-e173.

  25. Erpolat, S., Nazli, Y., Colak, N. y Yenidunya, S., “Leucocytoclasticvasculitis associated with clopidogrel”, CutanOcul Toxicol, 2012, 31 (2): 171-173.

  26. Ouni, B., Fathallah, N., Ben-Sayed, N., Slim, R., Abdessayed,N., Anoun, J. y Ben Salem, C., “Enalapril-lercanidipinecombination induced leukocytoclastic vasculitis: acase report”, Br J Clin Pharmacol, 2021, 87 (1): 210-211.

  27. Sato, A., Takemori, C., Fukumoto, T., Aoyama, N., Tajima,S., Fujiwara, S. y Nishigori, C., “Cutaneous leukocytoclasticvasculitis induced by thiamazole”, J Dermatol,2021, 48 (12): e604-e605.

  28. Wall, A.E., Weaver, S.M., Litt, J.S. y Rae, L., “Propylthiouracilassociated leukocytoclastic necrotizing cutaneousvasculitis: a case report and review of the literature”, JBurn Care Res, 2017, 38 (3): e678-e685.

  29. Chou, C.Y., Tsai, H.H., Cheng, C.J., Lin, Y.T. y Wang, K.H.,“Famciclovir-induced leukocytoclastic vasculitis”, J Dermatol,2012, 39 (8): 735-736.

  30. Czarnowicki, T., Ramot, Y., Ingber, A., Maly, A. y Horev,L., “Metformin-induced leukocytoclastic vasculitis: acase report”, Am J Clin Dermatol, 2012, 13 (1): 61-63.

  31. Odeh, M., Lurie, M. y Oliven, A., “Cutaneous leucocytoclasticvasculitis associated with omeprazole”, PostgradMed J, 2002, 78 (916): 114-115.

  32. Henley, J.K., Blackmon, J.A., Fraga, G.R., Rajpara, A. yMaz, M., “A case of glyburide-induced leukocytoclasticvasculitis”, Dermatol Online J, 2013, 19 (9): 19619.

  33. Appelman, M. y Wintzen, M., “Pruritus and leucocytoclasticvasculitis due to azathioprine”, Dermatology,2005, 210 (4): 366.

  34. Gupta, M.N., Sturrock, R.D. y Gupta, G., “Cutaneousleucocytoclastic vasculitis caused by cyclosporin a (Sandimmun)”,Ann Rheum Dis, 2000, 59 (4): 319.

  35. Ventura-Ribes, O., Machancoses, F.H. y Rosel Ramírez,J.F., “Vasculitis after blood pressure monitoring”, ReumatolClin, 2016, 12 (4): 216-218.

  36. Jolly, M. y Danila, M.I., “Tattoo: inflicted vasculitis?,” JClin Rheumatol, 2007, 13 (1): 49.

  37. Adams, B.B., “Exercise-induced vasculitis”, Arch Dermatol,2010, 146 (4): 449; réplica del autor: 450-451.

  38. Gogia, A., Kakar, A., Bhalla, S. y Byotra, S.P., “Leucocytoclasticvasculitis as a presentation of adenocarcinomarectum”, J Postgrad Med, 2005, 51 (3): 215-217.

  39. Bachmeyer, C., Moguelet, P., Marciano, S., Georgin-Lavialle,S., Monfort, J.B., Gkalea, V. y Mattioni, S., “Extensivepurpuric lesions due to vitamin c deficiency andleucocytoclastic vasculitis as the initial sign of lung adenocarcinoma”,Clin Exp Dermatol, 2019, 44 (3): e53-e54.

  40. Mebazaa, A., Chouk, S., Azzouz, H., El Euch, D., Rouhou,R.C., Trojjet, S., Mokni, M., Zitouna, M. y Ben Osman,A., “Leukocytoclastic vasculitis and gastric adenocarcinoma”,Acta Dermatovenerol Alp Pannonica Adriat,2010, 19 (1): 21-23.

  41. Nikkilä K, Mäkisalo H, Virolainen S. Cutaneous leukocytoclasticvasculitis in a patient with an adenocarcinomaof the colon. Duodecim. 2013;129(6):609-14.

  42. Guerouaz, N., Alaoui, M., Raiss, M., Hassam, B. y Senouci,K., “Systemic paraneoplastic vasculitis secondary topapillary carcinoma of the thyroid”, Clin Exp Dermatol,2016, 41 (6): 655-658.

  43. Martin, D., Handler, T. y McDermott, J., “Leucocytoclasticvasculitis in severe ulcerative colitis”, Mil Med, 2011,176 (5): 581-583.

  44. Rocha, T.B., Garate, A.L.S.V., Beraldo, R.F., Lanças,S.H.S., Leite, F.V., Quera, R., Barros, J.R., Baima, J.P.,Saad-Hossne, R. y Sassaki, L.Y., “Leukocytoclastic vasculitisas an extraintestinal manifestation of Crohn’s disease”,Case Rep Gastroenterol, 2021, 15 (3): 825-831.

  45. Liu, P.Y., Prete, P.E. y Kukes, G., “Leukocytoclastic vasculitisin a patient with type 1 cryoglobulinemia”, Case RepRheumatol, 2011, 2011: 124940.

  46. Miyagawa, F., Ogawa, K., Hashimoto, T. y Asada, H., “Acase of systemic lupus erythematosus with cutaneousleukocytoclastic vasculitis mimicking bullous sle”, CaseRep Dermatol, 2021, 13 (3): 464-469.

  47. Koutkia, P., Mylonakis, E., Rounds, S. y Erickson, A.,“Leucocytoclastic vasculitis: an update for the clinician”,Scand J Rheumatol, 2001, 30 (6): 315-322.




2020     |     www.medigraphic.com